| Literature DB >> 32295260 |
Emmanuel Navarro-Flores1, Daniel López-López2, Ricardo Becerro-de-Bengoa-Vallejo3, Marta Elena Losa-Iglesias4, Carlos Romero-Morales5, Marta San-Antolín-Gil6, César Calvo-Lobo3, Adolfo Laureano Bautista-Casasnovas7.
Abstract
Subungual osteochondroma (SO) is an infrequent and non-malignant bone tumour of the distal phalanx, especially prominent in paediatric populations. The aim of this research was to describe a case series of paediatric feet with SO which received surgical treatments. The secondary purpose was to compare these descriptive data by sex distribution.Entities:
Keywords: bone tumour; children; paediatric foot; subungual osteochondroma
Year: 2020 PMID: 32295260 PMCID: PMC7230394 DOI: 10.3390/jcm9041122
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Pre-surgery treatment, clinical appearance and X-ray images for one of the selected cases.
Figure 2Surgical procedure and clinical outcome of a case with subungual osteochondroma. Preoperative appearance of the lesion. Appearance immediately after the distal wing block anesthesia. Note the subungual mass.
Figure 3Curettage and removed subungual mass. Destruction of the nail bed after completion of the excision and curettage of the lesion. The nail plate was then debrided of all peripheral tissue and cleansed. The nail plate was sutured back into place, proximally and distally.
Figure 4Note subungual osteochondroma mass.
Socio-demographic characteristics of the sample population.
| Total Group | Male | Female | ||
|---|---|---|---|---|
| Age (years) | 11.13 ± 2.11 | 11.92 ± 2.10 | 10.10 ± 1.72 | 0.037 * |
| (8.00–16.00) | (9.00–16.00) | (8.00–12.00) | ||
| Weight (kg) | 38.60 ± 14.10 | 42.80 ± 25.15 | 37.15 ± 13.84 | 0.186 † |
| (36.72–47.69) | (31.90–77.55) | (27.90–48.00) | ||
| Height (m) | 1.45 ± 0.12 | 1.50 ± 0.12 | 1.39 ± 0.09 | 0.020 * |
| (1.25–1.74) | (1.34–1.74) | (1.25–1.52) | ||
| BMI (kg/m2) | 18.77 ± 3.16 | 18.57 ± 4.74 | 18.79 ± 1.95 | 0.927 † |
| (16.38–25.53) | (16.38–25.53) | (17.03–21.24) |
Abbreviations: BMI, body mass index; IR, Interquartile range; SD, standard deviation. * Mean ± SD, range (minimum–maximum), and Student t-test for independent samples were applied. † Median ± IR, range (minimum–maximum), and Mann–Whitney U test were applied. For all analyses, p-value < 0.05 (with a 95% confidence interval) was considered as statistically significant.
Clinical features of the sample population before intervention.
| Total Group | Male | Female | |||
|---|---|---|---|---|---|
| Lower limb side | Left | 10 (43.5%) | 5 (38.5%) | 5 (50%) | 0.685 * |
| Right | 13 (56.5%) | 8 (61.5%) | 5 (50%) | ||
| Toe location | 1st | 20 (86.8%) | 12 (92.3%) | 8 (80%) | 0.325 † |
| 2nd | 1 (4.4%) | 1 (7.7%) | 0 (0%) | ||
| 3rd | 0 (0%) | 0 (0%) | 0 (0%) | ||
| 4th | 1 (4.4%) | 0 (0%) | 1 (10%) | ||
| 5th | 1 (4.4%) | 0 (0%) | 1 (10%) | ||
| Tumour presence | Yes | 21 (91.3%) | 12 (92.3%) | 9 (90%) | 1.000 * |
| No | 2 (8.7%) | 1 (7.7%) | 1 (10%) | ||
| Pain presence | Yes | 16 (69.5%) | 9 (69.2%) | 7 (70%) | 1.000 * |
| No | 7 (30.5%) | 4 (30.8%) | 3 (30%) | ||
| Nail lift (yes/no) | Yes | 11 (47.8%) | 6 (46.1%) | 5 (50%) | 1.000 * |
| No | 12 (52.2%) | 7 (53.9%) | 5 (50%) | ||
* Frequency, percentage (%), and Fisher exact test were applied. † Frequency, percentage (%), and Chi-Square (χ2) test were applied. For all analyses, p-value < 0.05 (with a 95% confidence interval) was considered as statistically significant.
Clinical features of the sample population at one month after intervention.
| Total Group | Male | Female | |||
|---|---|---|---|---|---|
| Adverse effects | No | 6 (26.1%) | 4 (30.8%) | 2 (20%) | 0.523 † |
| Pain | 16 (69.5%) | 8 (61.5%) | 8 (80%) | ||
| Ulceration | 1 (4.4%) | 1 (7.7%) | 0 (0%) | ||
| Recurrence | Yes | 1 (4.4%) | 1 (7.7%) | 0 (0%) | 1.000 * |
| No | 22 (95.6%) | 12 (92.3%) | 10 (100%) | ||
* Frequency, percentage (%), and Fisher exact test were applied. † Frequency, percentage (%), and Chi-Square (χ2) test were applied. For all analyses, p-value < 0.05 (with a 95% confidence interval) was considered as statistically significant.